Inventor · disambiguated record
Ahmad Y. Sheikh
Also filed as: SHEIKH AHMAD · SHEIKH AHMAD Y
28 granted patents·16 pending applications·339 citations·filing 2002–2025
97Inventor score
Top patents by PatentIndex Score
44 records- 0198US11512092B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted Nov 29, 2022·21 cites·22 claims
- 0298US11198697B1Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2021·Granted Dec 14, 2021·29 cites·30 claims
- 0398US11186584B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2021·Granted Nov 30, 2021·28 cites·23 claims
- 0498US10981923B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[l,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2020·Granted Apr 20, 2021·32 cites·30 claims
- 0598US10017517B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluorethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2018·Granted Jul 10, 2018·41 cites·30 claims
- 0697US11680069B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted Jun 20, 2023·6 cites·30 claims
- 0797US11661425B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted May 30, 2023·9 cites·30 claims
- 0896US12234235B2Salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersALFASIGMA SPA·Filed 2023·Granted Feb 25, 2025·2 cites·4 claims
- 0995US9879018B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl and solid state forms thereofABBVIE INC·Filed 2017·Granted Jan 30, 2018·42 cites·30 claims
- 1094US12110298B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted Oct 8, 2024·1 cites·31 claims
- 1194US9879019B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2017·Granted Jan 30, 2018·42 cites·30 claims
- 1293US9382247B2Salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2015·Granted Jul 5, 2016·12 cites·2 claims
- 1392US7655657B2Fused bicycloheterocycle substituted quinuclidine derivativesABBOTT LAB·Filed 2007·Granted Feb 2, 2010·44 cites·5 claims
- 1491US11873320B22,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereofREATA PHARMACEUTICALS HOLDINGS LLC·Filed 2021·Granted Jan 16, 2024·2 cites·10 claims
- 1591US11117927B22,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereofABBVIE INC·Filed 2018·Granted Sep 14, 2021·3 cites·15 claims
- 1691US9856286B22,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereofABBVIE INC·Filed 2014·Granted Jan 2, 2018·14 cites·22 claims
- 1790US2024376115A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2024·Application pending·0 cites
- 1889US2024317770A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2024·Application pending·0 cites
- 1986US2023374027A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2023·Application pending·0 cites
- 2083US12384815B22,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereofREATA PHARMACEUTICALS HOLDINGS LLC·Filed 2024·Granted Aug 12, 2025·0 cites·19 claims
- 2182US2020291040A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2019·Application pending·0 cites
- 2279US7727953B2Crystalline form of a drugABBOTT LAB·Filed 2006·Granted Jun 1, 2010·2 cites·3 claims
- 2379US2025163071A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3,-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2025·Application pending·0 cites
- 2477US9321807B2Crystal formsABBVIE INC·Filed 2015·Granted Apr 26, 2016·2 cites·22 claims
- 2577US2021363149A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2021·Application pending·0 cites
- 2676US9469673B2Crystaline forms of HCV inhibitorABBVIE INC·Filed 2013·Granted Oct 18, 2016·4 cites·12 claims
- 2776US2025289816A1Salts and pharmacutical compositions thereof for the treatment of inflammatory disordersALFASIGMA SPA·Filed 2025·Application pending·0 cites
- 2869US7767850B2S-[2-[(1-iminoethy)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride crystalline saltPFIZER·Filed 2008·Granted Aug 3, 2010·1 cites·10 claims
- 2966US2022281882A1PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOFABBVIE INC·Filed 2022·Application pending·0 cites
- 3061US8592589B2Methods of treating cancer with a thieno[3,2-C]pyridineABBVIE INC·Filed 2012·Granted Nov 26, 2013·0 cites·12 claims
- 3160US2018094020A12,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereofABBVIE INC·Filed 2017·Application pending·0 cites
- 3260US2016376269A1Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersSABOURAULT NICOLAS LUC·Filed 2016·Application pending·0 cites
- 3357US9309279B2Macrocyclic hepatitis C serine protease inhibitorsABBVIE INC·Filed 2014·Granted Apr 12, 2016·0 cites·17 claims
- 3456US6872725B2Solid-state forms of N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl) pyrazolePHARMACIA CORP·Filed 2002·Granted Mar 29, 2005·2 cites·39 claims
- 3553US8357804B2Crystal forms of kinase inhibitorsABBVIE INC·Filed 2011·Granted Jan 22, 2013·0 cites·22 claims
- 3649US9561181B2Crystal formsABBVIE INC·Filed 2016·Granted Feb 7, 2017·0 cites·22 claims
- 3749US2015175612A1Crystal formsABBVIE INC·Filed 2014·Application pending·0 cites
- 3847US8399468B2Octahydro-pyrrolo[3,4-B]pyrrole derivativesCOWART MARLON D·Filed 2010·Granted Mar 19, 2013·0 cites·14 claims
- 3946US8633317B2Crystalline salts of thieno[3,2-c]pyridine kinase inhibitors with improved cpy safety profileZHANG GEOFF G Z·Filed 2011·Granted Jan 21, 2014·0 cites·30 claims
- 4046US2005165047A1Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereofPFIZER·Filed 2004·Application pending·0 cites
- 4146US2005038120A1S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride crystalline saltFiled 2004·Application pending·0 cites
- 4239US2004209956A1S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate form II crystalline saltFiled 2004·Application pending·0 cites
- 4338US2003232871A1Crystalline parecoxib sodiumFiled 2003·Application pending·0 cites
- 4435US2019202812A1Crystal FormsABBVIE INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ahmad Y. Sheikh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →